Publication
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3.
Journal Paper/Review - May 8, 2024
Goetz Matthew P, Toi Masakazu, Huober Jens, Sohn Joo Hyuk, Trédan Olivier, Park In Hae, Campone Mario, Chen S-C, Manso L M, Paluch-Shimon Shani, Freedman Orit C, O'Shaughnessy Joyce, Pivot X, Tolaney Sara M, Hurvitz Sara A, Llombart-Cussac Antonio, Andre Valerie A M, Saha A, van Hal G, Shahir Ashwin, Iwata H, Johnston Stephen R D
Goetz, Matthew P
6
0
Toi, Masakazu
6
0
Huober, Jens
chief physicianBrustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I
293
11
Sohn, Joo Hyuk
3
0
Trédan, Olivier
1
0
Park, In Hae
2
0
Campone, Mario
5
0
Chen, S-C
Manso, L M
Paluch-Shimon, Shani
2
0
Freedman, Orit C
1
0
O'Shaughnessy, Joyce
7
0
Pivot, X
Tolaney, Sara M
2
0
Hurvitz, Sara A
1
0
Llombart-Cussac, Antonio
1
0
Andre, Valerie A M
4
0
Saha, A
van Hal, G
Shahir, Ashwin
2
0